Oral Selinexor–Dexamethasone for Triple-Class Refractory Multiple Myeloma

Ajai Chari; Dan T. Vogl; Maria Gavriatopoulou; Ajay K. Nooka; Andrew J. Yee; Carol Ann Huff; Philippe Moreau; David Dingli; Craig E. Cole; Sagar Lonial; Meletios A Dimopoulos; A. Keith Stewart; Joshua Richter; Ravi Vij; Sascha A. Tuchman; Marc S. Raab; Katja Weisel; Michel Delforge; Robert F. Cornell; David Kaminetzky; James E. Hoffman; Luciano J. Costa; Terri L. Parker; Moshe Levy; Martin Schreder; Nathalie Meuleman; Laurent Frenzel; Mohamad Mohty; Sylvain Choquet; Gary J. Schiller; Raymond L. Comenzo; Monika Engelhardt; Thomas Illmer; Philip Vlummens; Chantal Doyen; Thierry Façon; Lionel Karlin; Aurore Perrot; Klaus Podar; Michael Kauffman; Sharon Shacham; Lingling Li; Shijie Tang; Carla Picklesimer; Jean‐Richard Saint‐Martin; Marsha Crochiere; Hua Chang; Samir Parekh; Yosef Landesman; Jatin J. Shah; Paul G. Richardson; Sundar Jagannath

doi:10.1056/nejmoa1903455

Related publications

Article2020

Overall survival with oral selinexor plus low‐dose dexamethasone versus real‐world therapy in triple‐class‐refractory multiple myeloma

Paul G. Richardson, Sundar Jagannath, Ajai Chari, Dan T. Vogl, Meletios A Dimopoulos, Philippe Moreau, David Dingli, Lee‐Jen Wei, Joshua Richter, Noa Biran, David S. Siegel, William M. Reichmann, Lingling Li, Shijie Tang, Jean‐Richard Saint‐Martin, Anita Joshi, Michael Kauffman, Jatin J. Shah, Sharon Shacham, Sagar Lonial

Article2019

Influence of Cytogenetics in Patients with Relapsed Refractory Multiple Myeloma Treated with Oral Selinexor and Dexamethasone: A Post-Hoc Analysis of the STORM Study

Ajay K. Nooka, Andrew J. Yee, Carol Ann Huff, Dan T. Vogl, Maria Gavriatopoulou, Ajai Chari, Philippe Moreau, David Dingli, Craig E. Cole, Sagar Lonial, Meletios A Dimopoulos, Joshua R. Richter, Ravi Vij, Sascha A. Tuchman, Marc S. Raab, Noa Biran, David S. Siegel, Paul G. Richardson, Jianjun Liu, Anita Joshi, Jatin J. Shah, Sharon Shacham,

Article2019

Response to Therapy and the Effectiveness of Treatment with Selinexor and Dexamethasone in Patients with Penta-Exposed Triple-Class Refractory Myeloma Who Had Plasmacytomas

Andrew J. Yee, Carol Ann Huff, Ajai Chari, Dan T. Vogl, Maria Gavriatopoulou, Ajay K. Nooka, Philippe Moreau, David Dingli, Craig E. Cole, Sagar Lonial, Meletios A Dimopoulos, Joshua R. Richter, Ravi Vij, Sascha A. Tuchman, James E. Hoffman, Luciano J. Costa, Terri L. Parker, Philip Vlummens, Chantal Doyen, Noa Biran, David S. Siegel,

Article2018

Results of the Pivotal STORM Study (Part 2) in Penta-Refractory Multiple Myeloma (MM): Deep and Durable Responses with Oral Selinexor Plus Low Dose Dexamethasone in Patients with Penta-Refractory MM

Ajai Chari, Dan T. Vogl, Meletios A Dimopoulos, Ajay K. Nooka, Carol Ann Huff, Philippe Moreau, Craig E. Cole, Joshua Richter, David Dingli, Ravi Vij, Sascha A. Tuchman, Marc S. Raab, Katja Weisel, Michel Delforge, David Kaminetzky, Robert F. Cornell, A. Keith Stewart, James E. Hoffman, Kelly Godby, Terri L. Parker, Moshe Levy,

Article2016

Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma

Meletios A Dimopoulos, Albert Oriol, Hareth Nahi, Jesús F. San Miguel, Nizar J. Bahlis, Saad Z. Usmani, Neil Rabin, Robert Z. Orlowski, Mieczysław Komarnicki, Kenshi Suzuki, Torben Plesner, Sung‐Soo Yoon, Dina Ben Yehuda, Paul G. Richardson, Hartmut Goldschmidt, Donna Reece, Steen Lisby, Nushmia Z. Khokhar, Lisa O’Rourke, Christopher Chiu, Xiang Qin, Mary Guckert, Tahamtan Ahmadi, Philippe Moreau